However, our results have not shown a higher level of S100A8/9 in patients with a poor prognosis of breast cancer (ER-negative/Her2-positive); also, this higher level was not observed in the lymph/vascular invasion positive group. This evidence concerns the gene ERBB2 and breast cancer.